The meeting was concerned with comparative aspects of asthmatic syndromes, many of which differ in aetiology in man and the horse, but which often respond to similar treatments. Dr A Williams (Beecham Pharmaceuticals Research, Surrey) discussed exercise-induced asthma in man. During exercise, peak expiratory flow in asthmatics may double, with rebound bronchoconstriction following up to 10 min after stopping exercise. This can be expressed as percentage rise/percentage fall in peak flow, the bronchial lability index.
Physiological changes in ventilation, perfusion and oxygen uptake have been studied. Red cell transit time through the lung is normally 0.75-1 s, equilibration of oxygen occurrs during the first 0.25 s. Arterial oxygen uptake is limited by the bronchial circulation shunt effect (1%), and relative ventilation: perfusion (V/Q) mismatch at the lung base, where gravity increases perfusion.
On exercise, the right ventricular output is increased, tending to reduce red cell transit time. Pao2 (arterial oxygen tension) is maintained by hyperventilation secondary to lactate accumulation, and a rise in the pulmonary artery pressure overcomes the V/Q imbalance at the lung base.
In fit athletes, as in race-fit horses, PaO2 falls on exercise, because of efficient oxygen extraction. In asthmatics, there is a V/Q imbalance at rest. Arterial oxygen tension falls on exercise despite bronchodilation, suggesting that ventilation is being limited at the level of small airways. The classical fall in forced expiratory volume after exercise also does not correlate with a fall in PaO2.
In asthmatics who voluntarily increase minute ventilation, the 'V/Q mismatch increases as increased RV output shifts blood to poorly ventilated areas with consequent hypoxia.
Nebulized salbutamol has been shown to increase the V/Q mismatch with a drop in oxygen saturation.
This brings into question the role of #2-agonists in exercise-induced asthma.
Dr C Friedman (Chase Farm Hospital, Enfield) discussed the features of the maximal flow volume loop in exercise in man. Expiratory and inspiratory flows on maximal effort are plotted against lung volume, inspiratory flow being represented as negative, to form a loop. In patients with severe chronic airflow limitation (CAL), the maximal expiratory flow is low due to reduced lung compliance and obstruction to airflow. Resting expiratory flow is already maximal, so there is no reserve for an increase on exertion.
In normal subjects, ventilation can be increased from 100 to 200 -mnin the first few seconds of exercise, and thereafter it is maintained at about 60% of maximum. In comparison, in CAL, the maximum is 30-40 /min. Limits to flow are imposed by the collapsibility of the airways, the support ofthe surrounding lung, and airway calibre. There is a valve effect, tending to close bronchi at the lobar/segmental level on expiration, when pleural pressure is far in excess of airway pressure.
The mechanisms ofincreased ventilation on exercise were demonstrated by studies ofthe flow volume loop. In normal subjects, tidal volume and flow both increase. As expiratory flow is maximal at rest in CAL, there is a compensatory shift of the curve towards a higher lung volume at which greater flow can be achieved for the same tidal volume. Thus, there is a reduction in inspiratory/expiratory time. When asthmatic patients voluntarily try to reproduce their exercise ventilation, this pattern is not maintained, tidal volume being much less, unless the traces are visibly superimposed during recording. Maintaining a constant tidal volume prevents wasted work through the high pleural pressures in expiration which cannot increase flow due to the limiting factors already mentioned.
Dr Friedman concluded that mechanical factors limited exercise capacity but the controlling mechanisms were uncertain.
Professor P J Barnes (Brompton Hospital, London) discussed the pathophysiology and therapy of asthma in man. The inflammatory nature of the condition is well recognized from postmortem histology, in which a predominantly eosinophil infiltrate, mucosal oedema and mucous plugging are seen. Even in well controlled asthmatics, inflammation is seen in bronchial biopsy specimens. The acute bronchoconstrictor response to agents such as histamine, cholinergic agonists, prostaglandins and sulphur dioxide is exaggerated in asthmatics, and this response remains enhanced for up to 7 days after allergen challenge.
It had been thought that mast cell mediator release was responsible for the bronchial hyperreactivity. However, mast cell stabilizers, such as sodium cromoglycate, were not effective in reducing bronchial hyperreactivity and had no effect on the late response to allergen, in contrast to the high efficacy of steroids in suppressing these phenomena. It may be that macrophages are activated by IgE receptor binding and stimulate inflammatory cells to produce mediators causing bronchoconstriction, microvascular leakage, mucus hypersecretion and bronchial hyperreactivity.
Epithelial loss and damage are seen in fatal asthma and experimental removal of the epithelial layer enhances the contractile response to spasmogens. Possible mechanisms include increased access after spasmogen, loss of a relaxant epithelial factor or metabolic process, and enhancement of a neural ieflex or mediator release. Epithelial damage may be secondary to deposition of eosinophil major base protein or oedema.
Platelet activating factor (PAF) is a potent bronchoconstrictor mediator released from inflammatory cells, which also promotes mucous secretion, impaired mucociliary clearance, a bronchial microvascular leak and prolonged bronchial hyperreactivity. In asthma, are more responsive to PAF and thus may be more prone to produce epithelium damaging factors, such as the major basic protein. Extracts of the Gingko leaf contain a PAF antagonist, which experimentally blocksthe late response to allergen. Its efficacy in chronic asthma has yet to be determined.
In conclusion, current therapy of asthma should be aimed at suppressing the inflammatory component by steroid administration, with the use of (2-receptor agonists for smooth muscle spa-sm. There are many nnadihilitia fnr t.ha Aivlrrnnmant nf hc'r -antiinflammatory agents.
Dr Tak Lee (Guy's Hospital, London) discussed the role of leukotrienes, the eosinophil and the macrophage in the pathogenesis ofbronchial asthma in man.
In contrast to COPD in the horse, an extrinsic allergic alveolitis, eosinophils were implicated more than neutrophils. They infiltrate the airways and deposit their major basicprotein. The deposition and infiltration correlate well with the severity of bronchial asthma.
Dr Lee considered some ofthe cellular-mechanisms involved. The sulphidopeptide leukotrienes C4, D4 and E4 (previously known as SRS-A) augmented the contractile response in guineapig ileum and histamine responsiveness in guineapig trachealis muscle in vitro. Removal of carboxyl and peptide side chains diminished the effect, suggesting that the response may be receptor mediated. In man, inhalation of sulphidopeptide-leukotrienes has demonstrated definite hyperresponsiveness to them in asthmatics, but a lesser respoase than to other agonists. In addition, inhalation of leukotriene E4, (LTE4) produced prolonged hyperresponsiveness to histamine, lasting up to 7 days.
Eosinophils can be stimulated to produce leukotriene C4, probably via transmembrane receptors, as FMLP (N-formyl-methionyl-leucylphenylalanine) increases-its production and it increases expression of the receptors.
Monocytes activated by lipopolysaccbaride produce a factor that stimulates ophil mediator production. This monokine is an heterogeneous acidic molecule, which differs from interleukmin-1. Alveolar g from asthmatics also enhance LTC4 generation by eosinophils.
Thus, the alveolar macrophage and monocyte have the capacity to increase the pro-inflammatory potential of the eosinophil. Dr Lee concluded that future treatment strategies should be directed towards cytokines at the cellular level.
Dr C J Hifledge (Animal Health Trust, Newmarket) reviewed studies carried out on exercise-induced hypoxia in trained horses using an inclined treadmill. The normal horse, exercising at a canter, breathes once per stride, locomotor forces supplementing respiratory effort. Studies using incremena work loads from 6 to 13 m/s showed initial hypoyaemia with no subsequent increase. This was achieved by increasing cardiac output, increasing the packed cell volume by mobilizing red cells stred in the spleen, and by ensauring adequate carbon dioxide transfer at the alveolus, thus achieving near maimal haemoglobin-oxygen saturation. Tidal volume increases threefold with exercise and initially respiratory rate increases to match increased stride rate. An increase in speed over 10 m/s is achieved by maintaining stride and respiratory rate and by increasing stride length. The limitation ofrespiratory rate is probably necessary to permit complete oxygen exchange at the alveolus. The limiting factor in equine exercise may be peak expiratory flow rate, which can be 60 to 70 1/s. Lower respiratory tract diseases, which can result in a considerable increase in total airway resistance, are very significant in high speed exercise.
Equine exercise induced pulmonary haemorrhage was reviewed by Mr PM Webbon (Royal Veterinary College, London). Epistaxis of pulmonary origin occurs in a small number of racehorses after fast exercise. Tracheal endoscopy and lavage after fast exercise has revealed the presence of blood or haemosiderin laden macrophages in many horses not showing clinical signs. The incidence of pulmonary haemorrhage is not affected by breed, climate, management system or country of origin. The syndrome is only seen in horses worked at a gallop, and is commoner in older animals.
Pulmonary haemorrhage was normally confined to the dorsocaudal angle of the lung, although cranial extension may occur,-in which case the ventral border ofthe lesions was roughly parallel to the ground. The lesions showed focal 'bonchiolitis with proliferation of bronchial vasculature. scintigraphic studies of ventilation-perfusion ratios in those areas has shown considerable mismatch, probably associated with shunting of blood from bronchial &rteries to the pulmonary circulation. Local hypoxia due to mismatching could result'in haemorrhage, which in turn promoted firther angiogenesis. Gravitational effects on ventilation and perfusion gradients might account for thee distribution ofthe lesions, although why they should be multifocal lesions is unclear.
The primary bronchiolitis may be initiated by rhinopneumonitis (equine herpes virus 1) or other viral infections when young racehorses enter training. If adequate treatment and convalescence were not instituted, a cycle of neovascularization and haemorrhage might ensue.
Dr Jill Thomson-(East of Scotland College of Agriculture Veterinary Investigation Clinic, Midlothian) described chronic obstructive pulmonary disease (COPD) in the horse. This allergic disease, associated with poor performance and coughing, is seen in all types of horse and increases in incidence with. age. Dyspnoea is evident and there is hypertrophy of abdominal muscles to aid expiration, taed with a double expiratory effort. Auscultation reveals inceased airwayZsounds throughout the chest, and crackling and wheezing in severe cases.
The main lesion is bronchiolitis, resulting in production of excess neutrophil-laden mucus and metaplasia of ciliated epithelium, and bronchospasm resulting in alveolar-overinflation, although emphysema is rare. Ther is peribronchial infiltration by mononuclear and some mast cells, Hay or straw with an excessive moisture content used in bedding or as feed becomes hot, encouraging growth of thermophilic moulds and spores (1-4 ym diameter) from theoe moulds act as inhled allergens in horses with COPD. Challenge results in a rapid response, followed by the main response 5 to 10 h after voluFL"Cllt, UL Utollial CLI&w-challenge, suggesting that both Type 1 and 3 hypersensitivity may be involved. Avoidance of hay and straw dust by changing stable management results in a good response in cases of COPD. Keeping the patient at grass is a satisfactory alternative, as few cases show pollen allergies.
Bronchodilators, such as j32-adrenergic agonists (e.g. clenbuterol), reduce the work of breathing in clinical cases to near a normal level (a 4 to 5-fold decrease), but do not affect the inflammatory infiltration, so a dust free regime remains preferable. The use of long term corticosteroid therapy carries the risk of laminitis in horses. Sodium cromoglycate by inhalation has a protective effect if used before challenge.
Respiratory tract immunology in the horse was described by Dr T S Mair (School of Veterinary Science, University of Bristol). The horse possesses organized submucosal nodules of lymphocytes in the upper respiratory tract, analogous to human tonsillar tissue. Nodules in the lower respiratory tract occur mainly at the division of airways. Antigen challenge results in enlargement of nodules. Sampling of antigen occurs by T-helper lymphocytes in nodules via the modified overlying epithelium. Sensitized lymphocytes migrate to lymph nodes and lead to the proliferation of effector lymphocytes which migrate back to the submucosa. The effector B lymphocytes secrete antibody, which is transported into the airway lumen; IgA predominates in the upper and IgG in the lower respiratory tract. Macrophages assist the immune response by presenting antigen to T helper lymphocytes and by secretion of mediators, which influence lymphocytic proliferation.
The predominant inflammatory cell in COPD is the neutrophil, which has a peak response 6-8 h after antigen challenge, coinciding with maximum airway hyper-reactivity. The neutrophil response may be to areas of complement activation in a Type 3 hypersensitivity reaction. Hypersensitization resulting in sufficient mucosal antibody to inactivate inhaled antigen before an allergic response is initiated is unlikely to be successful due to the multiple antigens involved. The recent performance of Rigoletto for the Royal Society of Medicine gave great enjoyment to and was of particular interest for all those present. The Otology Fellows were unanimously impressed by the resonance of the maxillary antra of all the main characters. The part of Rigoletto himself was excellently portrayed by a young baritone struggling against the disability of spinal ankylosis and spondylitis which, at first sight, caused concern to the Orthopaedic Section who feared that the cervical and thoracic deformity would impair the performance. Luckily, his acting technique enabled the audience to overlook the obvious in the true operatic tradition of suspending disbelief. Emotion overtook reason, and by the time that Rigoletto, in Act II, sang of his love for his daughter, there was scarcely a dry eye in the house, particularly among the Psychiatrists. And the daughter! Gilda, an apparent lure to en courage the attendance ofthe Clinical Immunologists, appeared to be, by innuendo, a case of immunodeficiency, tenderly protected from opportunistic infections by her father. She discovers, in a touching duet, that she acquired this from her mother. Alas, she meets the promiscuous Duke, and in the unforgettable farewell scene, where she repeats the word 'Addio' continuously to him, and he sympathetically replies, we realize that dementia has set in, luckily without the same aggressive tendencies (yet!) as seen in Lucia di Lammermoor, or even Tosca. In her aria 'Caro Nome' Gilda struggles to remember her lover's name, but her perception is too limited to realize that he is the Duke. The chorus, for the benefit of the Epidemiologists, become affected by mass hysteria expressed as the desire to be rid ofthe Duke. They capture Gilda whose affliction is spread to the Duke, much to the horror of her father. The Gynaecologists are called in as he sings of the Curse 'II maledetto'.
C Trigg
In the end, it is apparent that the part of the opera specially written by Verdi to attract the attention of the Odontologists, has failed. The Duke's halitosis problems continue to repel his new love, Maddalena. An alternative version, in which acne is mentioned, was not used, which probably accounted for the minimal representation of Fellows of the Section of Dermatology, very few of whom were spotted at the performance. The Duke's oculomotor system is shown deteriorating in the aria 'La Donna e Mobile', wherein the Ophthalmic Section were heard to applaud for encores as it became obvious that the Duke was unable to focus on the new object of his affections. In order to maintain a more even level of medical interest, an emergency tracheostomy is performed on stage by the local laryngologist, Sparafucile, a Member ofthe Society of Mediaeval Assassins (Fellow Historians were delighted by the realism).
An interesting twist to the plot is the final scene where Rigoletto is seen filing a medico-legal suit, whereupon members of the Medical Defence Union struck the only jarring note ofthe evening by leaving early. The matter will be discussed at an interdisciplinary cultural meeting to be chaired by the secretary of the Forensic Section. L Goldman Royal Opera House and English National Opera area of London WC2
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